Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
$ 18.695 0.245 (1.33%) Market Cap: 21.04 Bil Enterprise Value: 37.42 Bil PE Ratio: 0 PB Ratio: 3.30 GF Score: 59/100

Q3 2021 Teva Pharmaceutical Industries Ltd Earnings Call Transcript

Oct 27, 2021 / 12:00PM GMT
Release Date Price: $8.93 (-4.90%)
Operator

Good day, and thank you for standing by. Welcome to the Teva Pharmaceuticals Third Quarter 2021 Financial Results Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)

I would now like to hand the conference over to your first speaker today, Kevin Mannix, Senior Vice President of Investor Relations. Please go ahead.

Kevin C. Mannix
Teva Pharmaceutical Industries Limited - SVP of IR

Thank you, Nadia, and thanks, everyone, for joining us today to discuss Teva's third quarter 2021 financial results. Joining me on today's call is Kare Schultz, Teva's Chief Executive Officer; Eli Kalif, Chief Financial Officer; and Dr. Sven Dethlefs, Teva's Head of North America Commercial. We hope you've had an opportunity to review our press release, which was issued about an hour ago. A copy of the release and the slides being presented on this call can be found on our website at www.tevapharm.com.

Please note that the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot